According to recent literatures, VEGF exerts its biological functions through activating various downstream signaling pathways, including the classical PI3K/Akt/Nrf2 pathway, and activation of this signaling cascade facilitates cancer aggressiveness and drug resistance [45, 46]. This evidence concerns the gene AKT1 and cancer.